Q5S007 (LRRK2_HUMAN) Homo sapiens (Human)

Leucine-rich repeat serine/threonine-protein kinase 2 UniProtKBInterproStringInteractive Modelling

2527 aa; Sequence (Fasta)

Sequence Features

 1994Proton acceptor.
 50R -> H (in dbSNP:rs2256408). VAR_024931 dbSNP
 119L -> P (in dbSNP:rs33995463). VAR_024932 dbSNP
 228C -> S (in dbSNP:rs56108242). VAR_054740 dbSNP
 419A -> V (in dbSNP:rs34594498). VAR_033903 dbSNP
 551N -> K (in dbSNP:rs7308720). VAR_024933 dbSNP
 712M -> V (in PARK8; dbSNP:rs199566791). VAR_054741 dbSNP
 716A -> V (in dbSNP:rs281865043). VAR_054742 dbSNP
 723I -> V (in dbSNP:rs10878307). VAR_024934 dbSNP
 755P -> L (in dbSNP:rs34410987). VAR_033904 dbSNP
 793R -> M (in PARK8; unknown pathological significance; dbSNP:rs35173587). VAR_024935 dbSNP
 871K -> E (in dbSNP:rs281865044). VAR_054743 dbSNP
 930Q -> R (in PARK8; unknown pathological significance; dbSNP:rs281865045). VAR_024936 dbSNP
 944D -> Y (in dbSNP:rs17519916). VAR_024937 dbSNP
 1067R -> Q (in PARK8; dbSNP:rs111341148). VAR_024938 dbSNP
 1096S -> C (in PARK8; unknown pathological significance; dbSNP:rs76535406). VAR_024939 dbSNP
 1122I -> V (in PARK8; dbSNP:rs34805604). VAR_024940 dbSNP
 1228S -> T (in PARK8; dbSNP:rs60185966). VAR_024941 dbSNP
 1262P -> A (in dbSNP:rs4640000). VAR_024942 dbSNP
 1359K -> I (found in a renal cell carcinoma sample; somatic mutation). VAR_064728
 1371I -> V (in PARK8; unknown pathological significance; dbSNP:rs17466213). VAR_024943 dbSNP
 1375D -> E (in dbSNP:rs28365226). VAR_047022 dbSNP
 1398R -> H (in dbSNP:rs7133914). VAR_024944 dbSNP
 1441R -> C (in PARK; shows an increase in activity in both autophosphorylation and phosphorylation of a generic substrate; dbSNP:rs33939927). VAR_024945 dbSNP
 1441R -> G (in PARK8; shows a progressive reduction in neurite length and branching; dbSNP:rs33939927). VAR_024946 dbSNP
 1441R -> H (in PARK8; pathogenicity has yet to be confirmed; dbSNP:rs34995376). VAR_024947 dbSNP
 1514R -> Q (in PARK8; pathogenicity has yet to be confirmed; might have an effect on protein structure; dbSNP:rs35507033). VAR_024948 dbSNP
 1542P -> S (in PARK8; pathogenicity has yet to be confirmed; might have an effect on protein structure; dbSNP:rs33958906). VAR_024949 dbSNP
 1550R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs200212150). VAR_040678 dbSNP
 1598V -> E (in PARK8; pathogenicity has yet to be confirmed; might have an effect on protein structure; dbSNP:rs721710). VAR_024950 dbSNP
 1628R -> P (may be associated with Parkinson disease in some populations; dbSNP:rs33949390). VAR_024951 dbSNP
 1646M -> T (in dbSNP:rs35303786). VAR_024952 dbSNP
 1647S -> T (in dbSNP:rs11564148). VAR_024953 dbSNP
 1699Y -> C (in PARK8; shows no progressive reduction in neurite length and branching; dbSNP:rs35801418). VAR_024954 dbSNP
 1723R -> P (in an ovarian serous carcinoma sample; somatic mutation). VAR_040679
 1728R -> H (in PARK8; dbSNP:rs145364431). VAR_054744 dbSNP
 1728R -> L (in PARK8; dbSNP:rs145364431). VAR_054745 dbSNP
 1869M -> T (in PARK8; pathogenicity has yet to be confirmed; dbSNP:rs35602796). VAR_024955 dbSNP
 1870L -> F (in dbSNP:rs281865053). VAR_054746 dbSNP
 1906K -> M (does not inhibit interaction with RAB29; shows a progressive increase in neurite length and branching). VAR_071101
 1941R -> H (in PARK8; dbSNP:rs77428810). VAR_024956 dbSNP
 2012I -> T (in PARK8; pathogenicity uncertain; dbSNP:rs34015634). VAR_024957 dbSNP
 2019G -> S (in PARK8; shows an increase in activity in both autophosphorylation and phosphorylation of a generic substrate; results in increased PRDX3 phosphorylation promoting dysregulation of mitochondrial function and oxidative damage; does not inhibit interaction with RAB29; shows a progressive reduction in neurite length and branching; shows distinctive spheroid-like inclusions within both neuronal processes and at intracellular membranous structures; shows lysosomal swelling and reduced retrograde transport of selective cargo between lysosomes and the Golgi apparatus; shows apoptotic mechanism of cell death; dbSNP:rs34637584). VAR_024958 dbSNP
 2020I -> T (in PARK8; significant increase in autophosphorylation of about 40% in comparison to wild-type protein in vitro; shows a progressive reduction in neurite length and branching; dbSNP:rs35870237). VAR_024959 dbSNP
 2081N -> D (in dbSNP:rs33995883). VAR_024960 dbSNP
 2119P -> L (in dbSNP:rs12423862). VAR_024961 dbSNP
 2141T -> M (in PARK8; dbSNP:rs111691891). VAR_054747 dbSNP
 2143R -> H (in PARK8; dbSNP:rs201271001). VAR_054748 dbSNP
 2261N -> I (in dbSNP:rs12581902). VAR_024962 dbSNP
 2356T -> I (in PARK8; dbSNP:rs113511708). VAR_024963 dbSNP
 2385G -> R (associated with Parkinson disease; under conditions of oxidative stress the variant protein is more toxic and is associated with a higher rate of apoptosis; reduced binding to synaptic vesicles; dbSNP:rs34778348). VAR_024964 dbSNP
 2395E -> K (in dbSNP:rs78964014). VAR_054749 dbSNP
 2397M -> T (in dbSNP:rs3761863). VAR_024965 dbSNP
 2466L -> H (in PARK8; dbSNP:rs281865057). VAR_054750 dbSNP
 1341-1348GTP.
 1885-1893ATP.
 2098-2121GTP.
 2295-2298GTP.
 1012-1070Leucine-rich repeat
IPR001611PF13855
 1246-1284Leucine rich repeat 4
IPR025875PF12799
 1545-1740C-terminal of Roc (COR) domain
IPR032171PF16095
 1885-2129Protein kinase domain
IPR000719PF00069

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownload
Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS910 Heteromer
Q5S007; P31947;
NA;CA;CL;5myc904-941
Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS935 Heteromer
Q5S007; P31947;
CA;CL;5my9929-941
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 ...homo-2-mer GDP;MG;2zej1333-1516
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 ...homo-2-mer GDP;MG;3d6t1335-1505

Homology models

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownload
monomer -4.203dpu.1.A1309-1858
18.11